Cargando…
Cost-Effectiveness of Pharmacological Treatments for Osteoporosis Consistent with the Revised Economic Evaluation Guidelines for Canada
Introduction. Given the lack of independent analyses comparing numerous pharmacotherapies for osteoporosis, the study objective was to identify the optimal osteoporosis treatment based on a woman’s age, fracture history, and ability to tolerate oral bisphosphonates adopting practices recommended in...
Autor principal: | Coyle, Doug |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357295/ https://www.ncbi.nlm.nih.gov/pubmed/30729168 http://dx.doi.org/10.1177/2381468318818843 |
Ejemplares similares
-
Effects of the Revised Reimbursement Guideline for Anti-Osteoporosis Medication in South Korea
por: Ko, Young-Seung, et al.
Publicado: (2022) -
Effect of the UK’s revised paracetamol poisoning management guidelines on admissions, adverse reactions and costs of treatment
por: Bateman, D Nicholas, et al.
Publicado: (2014) -
The cost-effectiveness of schistosomiasis screening and treatment among recently resettled refugees to Canada: an economic evaluation
por: Webb, John A., et al.
Publicado: (2021) -
Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition
por: Won, Eunsoo, et al.
Publicado: (2014) -
Cost-effectiveness of cannabinoids for pediatric drug-resistant epilepsy: protocol for a systematic review of economic evaluations
por: Elliott, Jesse, et al.
Publicado: (2019)